[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] #  @BalaBioResearch BalaBio Research BalaBio Research posts on X about $slno, $acad, money, $rytm the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours. ### Engagements: XXXXX [#](/creator/twitter::1930394110906580992/interactions)  - X Week XXXXX -XX% - X Month XXXXXX +27% ### Mentions: X [#](/creator/twitter::1930394110906580992/posts_active)  - X Week XX -XX% - X Month XX -XXXX% ### Followers: XXXXX [#](/creator/twitter::1930394110906580992/followers)  - X Week XXXXX +1.40% - X Month XXXXX +20% ### CreatorRank: XXXXXXX [#](/creator/twitter::1930394110906580992/influencer_rank)  ### Social Influence [#](/creator/twitter::1930394110906580992/influence) --- **Social category influence** [finance](/list/finance) XXXX% [stocks](/list/stocks) XXXX% [technology brands](/list/technology-brands) XXXX% **Social topic influence** [$slno](/topic/$slno) #3, [$acad](/topic/$acad) 2.91%, [money](/topic/money) 1.94%, [$rytm](/topic/$rytm) #15, [approved](/topic/approved) #942, [$ocul](/topic/$ocul) #5, [upside](/topic/upside) 0.97%, [$tnxp](/topic/$tnxp) 0.97%, [$cort](/topic/$cort) 0.97%, [$crnx](/topic/$crnx) XXXX% **Top accounts mentioned or mentioned by** [@lcccc333](/creator/undefined) [@biotech2k1](/creator/undefined) [@jeremyj0916](/creator/undefined) [@melvinriskmgmt](/creator/undefined) [@aditharun](/creator/undefined) [@epickram](/creator/undefined) [@yachmod](/creator/undefined) [@physioo](/creator/undefined) [@financebully](/creator/undefined) [@clarkjon88](/creator/undefined) [@dedwng](/creator/undefined) [@mickeychiku](/creator/undefined) [@phoenix3million](/creator/undefined) [@sanctuarybio](/creator/undefined) [@pikacapital](/creator/undefined) [@alexahdoot](/creator/undefined) [@mbbiotech](/creator/undefined) [@plainyogurt21](/creator/undefined) [@rudyresearch](/creator/undefined) [@biotechsanya2](/creator/undefined) **Top assets mentioned** [Soleno Therapeutics, Inc. Common Stock (SLNO)](/topic/$slno) [Acadia Pharmaceuticals Inc. (ACAD)](/topic/$acad) [Rhythm Pharmaceuticals, Inc. Common Stock (RYTM)](/topic/$rytm) [Corcept Therapeutics Inc. (CORT)](/topic/$cort) [Crinetics Pharmaceuticals, Inc. (CRNX)](/topic/$crnx) [Neurocrine Biosciences, Inc. (NBIX)](/topic/$nbix) [BioMarin Pharmaceutical, Inc. (BMRN)](/topic/$bmrn) [uniQure N.V. (QURE)](/topic/$qure) ### Top Social Posts [#](/creator/twitter::1930394110906580992/posts) --- Top posts by engagements in the last XX hours "$SLNO Seeing some analyst coverage on this and I think its really important Vykat has weight based dosing and does NOT have a flat price per patient revenue could massively surprise to the upside off titration from launch q patients" [X Link](https://x.com/BalaBioResearch/status/1978529272055672956) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-15T18:31Z 1024 followers, 3355 engagements "$TNXP just watched $ACAD fail their carbetocin trial and decided now its their turn to waste money on oxytocin agonists in prader willi syndrome" [X Link](https://x.com/BalaBioResearch/status/1973803931802477027) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-02T17:35Z 1025 followers, 2075 engagements "Swapping my $SLNO Nov 60C for shares same size position but much less leveraged. I dont want the smoke if $RYTM early drops the phase X and I also don't want to be as exposed to more irrational FAERS drops or whatever this was. I will probably exit my position quickly after ER" [X Link](https://x.com/BalaBioResearch/status/1973427294497882395) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-01T16:38Z 1026 followers, 2299 engagements "Anyone have a list of successful drugs which have shown inverse dose response The $ACAD thesis is that higher dose carbetocin binds to too many vassopressin receptors counteracting the hyperphagia effects of the OXTR activation. Id rather go with the prior 3.2mg hit being noise" [X Link](https://x.com/BalaBioResearch/status/1969468698948768252) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-20T18:28Z 1024 followers, 3015 engagements "$CORT $CRNX $NBIX $XERS Question for endos would you still classify someone as an endogenous Cushing's Syndrome patient if they tested for high cortisol levels in a DST but there was no abnormal growth in the adrenal gland or causal tumor from a CT scan or MRI" [X Link](https://x.com/BalaBioResearch/status/1957474006988149111) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-08-18T16:05Z 1024 followers, 1980 engagements "Half these assets are worthless but $RZLT makes a lot of sense for $BMRN" [X Link](https://x.com/BalaBioResearch/status/1968414894299959500) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-17T20:40Z 1024 followers, 3240 engagements "$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved" [X Link](https://x.com/BalaBioResearch/status/1977214065178264007) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-12T03:25Z 1024 followers, 2074 engagements "$SLNO $ACAD carbetocin fail no reported p value and no separation from pbo on any secondary endpoint" [X Link](https://x.com/BalaBioResearch/status/1970816990404374719) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-24T11:46Z 1024 followers, 4027 engagements "What do we think $QURE is gonna spend their money on when they have 3b of free cash flow in 2030" [X Link](https://x.com/BalaBioResearch/status/1975651180769583561) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-07T19:55Z 1026 followers, 2778 engagements "The best biotwit posts come when data is late $ovid" [X Link](https://x.com/BalaBioResearch/status/1973170141019119669) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-30T23:36Z 1026 followers, 4646 engagements "So is the $OCUL story just that they either have the next Eylea or theyre a 0" [X Link](https://x.com/BalaBioResearch/status/1973160980772430103) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-30T23:00Z 1025 followers, 3849 engagements "$AARD $SLNO $RYTM This a a great visualization of the MC4R pathway from RYTMs new presentation. Remember that in PWS the POMC neurons are underactive and the AgRP neurons are overactive each causing there to be less MC4R activation" [X Link](https://x.com/BalaBioResearch/status/1965519156281004356) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-09-09T20:54Z 1024 followers, 2738 engagements "@MelvinRiskMgmt @plainyogurt21 Look at their operations they barely have any overhead at all. No r&d and a tiny salesforce. The patients seek the drug" [X Link](https://x.com/BalaBioResearch/status/1978609596303396944) [@BalaBioResearch](/creator/x/BalaBioResearch) 2025-10-15T23:51Z 1024 followers, XXX engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@BalaBioResearch BalaBio Research
BalaBio Research posts on X about $slno, $acad, money, $rytm the most. They currently have XXXXX followers and XXX posts still getting attention that total XXXXX engagements in the last XX hours.
Engagements: XXXXX #
- X Week XXXXX -XX%
- X Month XXXXXX +27%
Mentions: X #
- X Week XX -XX%
- X Month XX -XXXX%
Followers: XXXXX #
- X Week XXXXX +1.40%
- X Month XXXXX +20%
CreatorRank: XXXXXXX #
Social Influence #
Social category influence finance XXXX% stocks XXXX% technology brands XXXX%
Social topic influence $slno #3, $acad 2.91%, money 1.94%, $rytm #15, approved #942, $ocul #5, upside 0.97%, $tnxp 0.97%, $cort 0.97%, $crnx XXXX%
Top accounts mentioned or mentioned by @lcccc333 @biotech2k1 @jeremyj0916 @melvinriskmgmt @aditharun @epickram @yachmod @physioo @financebully @clarkjon88 @dedwng @mickeychiku @phoenix3million @sanctuarybio @pikacapital @alexahdoot @mbbiotech @plainyogurt21 @rudyresearch @biotechsanya2
Top assets mentioned Soleno Therapeutics, Inc. Common Stock (SLNO) Acadia Pharmaceuticals Inc. (ACAD) Rhythm Pharmaceuticals, Inc. Common Stock (RYTM) Corcept Therapeutics Inc. (CORT) Crinetics Pharmaceuticals, Inc. (CRNX) Neurocrine Biosciences, Inc. (NBIX) BioMarin Pharmaceutical, Inc. (BMRN) uniQure N.V. (QURE)
Top Social Posts #
Top posts by engagements in the last XX hours
"$SLNO Seeing some analyst coverage on this and I think its really important Vykat has weight based dosing and does NOT have a flat price per patient revenue could massively surprise to the upside off titration from launch q patients"
X Link @BalaBioResearch 2025-10-15T18:31Z 1024 followers, 3355 engagements
"$TNXP just watched $ACAD fail their carbetocin trial and decided now its their turn to waste money on oxytocin agonists in prader willi syndrome"
X Link @BalaBioResearch 2025-10-02T17:35Z 1025 followers, 2075 engagements
"Swapping my $SLNO Nov 60C for shares same size position but much less leveraged. I dont want the smoke if $RYTM early drops the phase X and I also don't want to be as exposed to more irrational FAERS drops or whatever this was. I will probably exit my position quickly after ER"
X Link @BalaBioResearch 2025-10-01T16:38Z 1026 followers, 2299 engagements
"Anyone have a list of successful drugs which have shown inverse dose response The $ACAD thesis is that higher dose carbetocin binds to too many vassopressin receptors counteracting the hyperphagia effects of the OXTR activation. Id rather go with the prior 3.2mg hit being noise"
X Link @BalaBioResearch 2025-09-20T18:28Z 1024 followers, 3015 engagements
"$CORT $CRNX $NBIX $XERS Question for endos would you still classify someone as an endogenous Cushing's Syndrome patient if they tested for high cortisol levels in a DST but there was no abnormal growth in the adrenal gland or causal tumor from a CT scan or MRI"
X Link @BalaBioResearch 2025-08-18T16:05Z 1024 followers, 1980 engagements
"Half these assets are worthless but $RZLT makes a lot of sense for $BMRN"
X Link @BalaBioResearch 2025-09-17T20:40Z 1024 followers, 3240 engagements
"$OCUL is very interesting at this valuation even if you think SOL-1 has a XX% POS. Imagine the amount of people with wet AMD who just ask their doctor: "give me whatever has the least IVI's but still works." Easily a multi billion dollar drug if approved"
X Link @BalaBioResearch 2025-10-12T03:25Z 1024 followers, 2074 engagements
"$SLNO $ACAD carbetocin fail no reported p value and no separation from pbo on any secondary endpoint"
X Link @BalaBioResearch 2025-09-24T11:46Z 1024 followers, 4027 engagements
"What do we think $QURE is gonna spend their money on when they have 3b of free cash flow in 2030"
X Link @BalaBioResearch 2025-10-07T19:55Z 1026 followers, 2778 engagements
"The best biotwit posts come when data is late $ovid"
X Link @BalaBioResearch 2025-09-30T23:36Z 1026 followers, 4646 engagements
"So is the $OCUL story just that they either have the next Eylea or theyre a 0"
X Link @BalaBioResearch 2025-09-30T23:00Z 1025 followers, 3849 engagements
"$AARD $SLNO $RYTM This a a great visualization of the MC4R pathway from RYTMs new presentation. Remember that in PWS the POMC neurons are underactive and the AgRP neurons are overactive each causing there to be less MC4R activation"
X Link @BalaBioResearch 2025-09-09T20:54Z 1024 followers, 2738 engagements
"@MelvinRiskMgmt @plainyogurt21 Look at their operations they barely have any overhead at all. No r&d and a tiny salesforce. The patients seek the drug"
X Link @BalaBioResearch 2025-10-15T23:51Z 1024 followers, XXX engagements